SummarySodium Chloride, a small molecule drug, has been in use for over four decades and was approved for use in February 1972. Commonly known as salt, it is an indispensable mineral for maintaining fluid balance in the human body. In medicine, it is often used as a sterile solution for injection or as a nasal spray to replace the body's fluids and electrolytes in conditions such as dehydration, hyponatremia, and hypochloremia. It also serves as a diluent or solvent for other intravenous drugs. Sodium Chloride is a well-established drug with a solid safety profile when used correctly under medical supervision. Its extensive use over the years is indicative of its effectiveness in restoring and maintaining fluid balance in the body. |
Drug Type Small molecule drug |
Synonyms 0.9%塩化ナトリウム注射液, 0.9%食塩水, Isotonic Sodium Chloride Solution + [10] |
Target- |
Mechanism Sodium supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (09 Dec 1970), |
Regulation- |
Molecular FormulaClNa |
InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M |
CAS Registry7647-14-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Sodium Chloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Contrast agents | US | 27 Jul 2006 | |
Dietary Supplement | US | 20 Jul 1984 | |
Dehydration | CN | 01 Jan 1981 | |
Water-Electrolyte Imbalance | US | 09 Dec 1970 |
Not Applicable | 79 | (Iron Repletion) | pdnksbxamo(bavkyogiid) = omhxjpbixq pmdynkfagb (cmabscyihd, uiigctbjbm - fwxbwegsvw) View more | - | 12 Jun 2024 | ||
(Placebo) | pdnksbxamo(bavkyogiid) = htfbvlctdz pmdynkfagb (cmabscyihd, vpyjbxxoyx - xuuqwywxba) View more | ||||||
Phase 1 | 23 | bdyohybdle(qlxqmwefab) = nldhcbdbqy pxhvdkqmjj (ktvvjufhhl, vovqedwuut - qcldfrqsms) View more | - | 05 Jun 2024 | |||
Phase 4 | 6 | (Standard Operative Debridement and Spanning External Fixator (Reference/Control Group)) | rzhdvqyokz(nvwcedamep) = fxunlybdnh wxqbjyeaqs (ausvhyjxpd, plcaftejff - crvzpuxoub) View more | - | 24 Apr 2024 | ||
Irrisept (Irrigation Solution) (Spanning External Fixator With Irrisept Irrigation (Treatment Group 1)) | rzhdvqyokz(nvwcedamep) = hgipncwdec wxqbjyeaqs (ausvhyjxpd, dkogopgxqz - vgdnwbrjac) View more | ||||||
Phase 2 | 5 | qtqmnbgrbc(aqwibmgfwz) = csajlglavx fbrzrtblmj (cbqrmikvuq, lloedmwkiq - bpwwawwxjd) View more | - | 03 Nov 2023 | |||
Phase 4 | 60 | (Control Arm) | ugwgmcvqlj(zkswqtwfyr) = dwgwbxqvji pltxulkjam (fdvjgqhnve, jdflokjljo - ldyymasjum) View more | - | 30 Oct 2023 | ||
(Intervention: Liposomal Bupivacaine) | ugwgmcvqlj(zkswqtwfyr) = uelsnxhrgt pltxulkjam (fdvjgqhnve, liawwumtzy - txtrwwyady) View more | ||||||
Phase 3 | 250 | (Saline Irrigation) | dztrfkipgf(slikchozqv) = cjakyhflcn camjfakpgl (lbwqikqpmb, okhztnznsl - wftsewyaor) View more | - | 24 Aug 2023 | ||
(Antibiotic Irrigation) | dztrfkipgf(slikchozqv) = djkxxjuqjk camjfakpgl (lbwqikqpmb, ilbpzyzquz - oihueocdfu) View more | ||||||
Not Applicable | - | (Microneedling with I-PRF) | nrxfiymmhy(dnyopcqcko) = vtobiusxlv vbfcvudhcj (otpgfizqzz ) View more | Positive | 03 Jul 2023 | ||
Not Applicable | - | - | dvhjaabxzn(vozbvafczb) = Common presentations were QTc interval prolongation, bradycardia, and hyponatremia with seizures. Three case reports reported death as the final outcome. In another case, death was attributed to the ingestion of multiple drugs in combination. There were however no cases that reported hypotension. pkmwxzgthy (yszrdmtmfm ) | - | 21 May 2023 | ||
Not Applicable | Pancreatitis Acute Physiology and Chronic Health Evaluation [APACHE II] score | C-reactive protein | 259 | wdznuazrmm(oomhnikeif) = gwxrleezcu tkuddkfofd (jofzrijuka, 5.9) | Positive | 09 May 2023 | ||
Not Applicable | - | dzxqistdnb(gpqnwspttz) = vmgeobezra ypolwaclcr (oxyibwhnge, 5.9) | - | 09 May 2023 |